RevealDx Receives FDA Clearance for AI Powered Lung Nodule Risk Assessment
recent articles
PathAI: The three research posters demonstrate how artificial intelligence may improve the research and clinical utility of various biomarker programs Boston, MA | October 11, 2023 10:00 AM Eastern Daylight Time - PathAI, a global leader...
Ibex: More Than 10,000 Patient Cases Diagnosed Using Ibex's AI Platform; CorePlus Expands its AI Deployment to Primary Diagnosis BOSTON and CAROLINA, Puerto Rico, Oct. 10, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader...
From the Grundium blog: What do pathology professionals want to know about WSI? In the dynamic world of medical diagnostics, Whole Slide Imaging (WSI) emerges as a game-changer in pathology. Many professionals grapple with its nuances as the...
Lumea: The FDA's recent move to treat Laboratory Developed Tests (LDTs) as medical devices has sent ripples through the industry. With the absence of a passed legislation in 2022, the FDA has taken a pivotal step, emphasizing its...
PathAI: The lab will support clinical trials across oncology, liver, and GI indications, with expansion to additional indications in the future. Boston, MA – September 19, 2023 – PathAI, a global leader in AI-powered pathology,...
Lunit 6 posters unveil new tumor microenvironment insights and the predictive power of Lunit SCOPE across diverse cancer types at SITC 2023 SEOUL, South Korea, Sept. 27, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of...
